Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Melanoma
This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of melanoma treatment. Due to recent drug approvals and increasing ability to offer combined agents, there are many more treatment options available to melanoma patients than even a few years ago. Especially significant are the recent FDA approval of the immunotherapeutic agent ipilimumab for metastatic melanoma, and new agents targeting the BRAF gene in malignant melanoma (these two developments cited among the top 5 most significant advances in oncology for 2011). There is also coverage of the most recent data pertaining to surgical management, staging and prevention, and melanoma in children. The authorship of the articles is outstanding and represents national and global authorities on the topics reviewed.
Melanoma
Emerging Cancer Therapeutics is a trinary hard cover periodical that is designed to provide an up-to-date evidence-based review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists involved in the care of patients receiving cancer treatment. It will serve as both a reference and instructional tool for students, housestaff, fellows, practicing clinical oncologists, radiation oncologists, surgical oncologists, cancer biologists, and interdisciplinary colleagues throughout the oncology spectrum. With contributions from nationally recognized experts representing the fields of dermatology, dermatologic surgery, surgical oncology, dermatopathology, and medical oncology, Melanoma includes chapters on prevention, changes in melanoma staging, the evolving role of established surgical therapies, single-agent specific V600E mutant inhibitors, target therapy for patients without BRAF mutations, new treatments for metastatic melanoma-including ipilimumab and vemurafenib-and more.
Lymphomas
This work for oncologists and cancer biologists provides eight chapters on the evolving role of established therapies as well as pathway-directed agents, within the context of the emerging paradigm of personalized lymphoma treatment. The disease specific chapters describe signaling pathways central to disease pathology, but also emphasize the biological heterogeneity of the entities currently recognized by the WHO Classification and stress the importance of this heterogeneity when considering treatment choices. The book examines new and emerging therapies for Hodgkin and non-Hodgkin lymphoma, T-cell lymphoma, indolent lymphoma, mantle cell lymphoma, and aggressive B-cell lymphoma. Treatments described include autologous hematopoietic stem cell transplantation, allogenic stem cell transplantation, and non-transplant-based salvage therapy. Sweetenham teaches medicine at UCSD Nevada Cancer Institute in Las Vegas. Annotation ©2012 Book News, Inc., Portland, OR (booknews.com).
Published Scientific Papers of the National Institutes of Health
Presents the broad outline of NIH organizational structure, theprofessional staff, and their scientific and technical publications covering work done at NIH.
Lung Cancer
With contributions from internationally recognized experts, Lung Cancer details the current management of lung cancer and reviews new therapies in development for lung cancer, with an emphasis on therapeutic exploitation of the heterogeneous nature of lung tumors at the molecular level. Coverage includes discussion of multiple new agents that have been shown to impact overall survival as well as articles covering molecular biology of lung cancer, chemotherapy regimens for lung cancer, the emergence of maintenance therapy, the complexity of radiotherapy in the chest, the impact of adjuvant chemotherapy for resected non-small cell lung cancer, surgical considerations for early-stage lung cance...
Abeloff's Clinical Oncology E-Book
Carrying on the tradition established by its founding editor, the late Dr. Martin Abeloff, the 4th Edition of this respected reference synthesizes all of the latest oncology knowledge in one practical, clinically focused, easy-to-use volume. It incorporates basic science, pathology, diagnosis, management, outcomes, rehabilitation, and prevention – all in one convenient resource – equipping you to overcome your toughest clinical challenges. What's more, you can access the complete contents of this Expert Consult title online, and tap into its unparalleled guidance wherever and whenever you need it most! Equips you to select the most appropriate tests and imaging studies for diagnosing and...
Scientific Directory and Annual Bibliography
Each issue lists papers published during the preceding year.
Journal of the National Cancer Institute
"Summaries of papers" contained in the journal accompany each issue, 19--
